Discovering therapeutic antibodies designed by nature


Nature Medicine publication

December 22, 2014 - A Netherlands Cancer Institute (NKI) publication co-authored by AIMM Therapeutics in Nature Medicine reveals that recognition of neo-antigens by CD4+ T cells is a common phenomenon in melanoma.

PNAS publication

December 11, 2014 - A bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity

AIMM Therapeutics’ 10 year anniversary symposium

October 3, 2014 - You are cordially invited to our 10 year anniversary symposium on November 20, 2014.

MedImmune Starts Clinical Studies with RSV Antibody

July 2, 2014 - MedImmune has initiated phase I clinical studies with MEDI8897, a best-­in-­class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.